NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 138 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,498,295 | +21.4% | 77,955 | +60.6% | 0.01% | +28.6% |
Q2 2023 | $1,233,938 | +32.0% | 48,542 | +798.3% | 0.01% | +16.7% |
Q4 2020 | $935,000 | -24.8% | 5,404 | -48.1% | 0.01% | -25.0% |
Q2 2020 | $1,244,000 | -23.5% | 10,410 | -36.0% | 0.01% | -33.3% |
Q1 2020 | $1,626,000 | -15.0% | 16,266 | -0.1% | 0.01% | +33.3% |
Q4 2019 | $1,914,000 | +114.3% | 16,282 | +56.8% | 0.01% | +125.0% |
Q3 2019 | $893,000 | +4600.0% | 10,384 | +3662.3% | 0.00% | – |
Q4 2015 | $19,000 | -45.7% | 276 | -57.2% | 0.00% | – |
Q2 2015 | $35,000 | – | 645 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |